EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudieOpen Access · CC BY-NC-ND 4.0

The long-term survival outcome of sporadic bilateral renal cell carcinoma and optimization of surgical treatment: a large-scale population-based cohort study

Ruiyi Deng, Jianhui Qiu, Jiaheng Shang, Chaojian Yu, Peidong Tian, Zihou Zhao, Lin Cai, Jingcheng Zhou, Kan Gong

Clinical and Experimental Medicine · 2024

DOI: 10.1007/s10238-024-01535-5 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical and Experimental Medicine, 2024. Verfasst von Ruiyi Deng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Nephrectomy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Beijing Municipality, National High Level Hospital Clinical Research Funding (High Quality Clinical Research Project of Peking University First Hospital), National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sporadic bilateral renal cell carcinoma (BRCC) is a rare situation of RCC. The treatment for BRCC is controversial and there is a lack of authoritative guidelines about the management of BRCC. Patients diagnosed with sporadic BRCC between 2004 and 2020 were identified from Surveillance, Epidemiology, and End Results (SEER) database. The primary outcome was overall survival (OS). Kaplan-Meier survival analysis, Cox regression analysis, and competing risk regression models were used to compare survival outcomes and identify prognostic factors. A total of 20,523 patients (16,534 unilateral RCC [URCC] patients and 3989 BRCC patients) were included. The prognosis of BRCC patients is between metastatic and non-metastatic URCC patients. 3677 patients were diagnosed with localized BRCC (2180 synchronous BRCC patients and 1497 metachronous BRCC patients). Compared with metachronous BRCC, synchronous BRCC patients had relatively poor OS. However, the CSS was similar. Partial nephrectomy (PN) leads to the best OS and provides equivalent oncological outcomes to radical nephrectomy. Local tumor destruction (LTD) could also achieve an acceptable cancer-control effect. Then we developed treatment flowchart for localized BRCC patients. Additionally, we identified the prognostic factors, and analyzed the association between factors using the multivariable Cox regression method. PN should be the initial treatment for sporadic localized BRCC patients if feasible. LTD could be considered as an effective treatment alternative. This study could provide evidence for the optimization of individualized treatment for sporadic BRCC patients.Trial registration: The trial was registered on the ClinicalTrials.gov (NCT06369519).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsNephrectomyAdultAgedFemaleHumansMaleMiddle AgedCohort StudiesKaplan-Meier EstimatePrognosisSEER ProgramSurvival AnalysisTreatment Outcome

Stichwörter der Autor:innen

Bilateral renal cell carcinomaLocal tumor destructionNomogramPartial nephrectomySurgery

Autor:innen und Institutionen

  • Department of Urology, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China.
  • Institute of Urology, Peking University, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China.
  • National Urological Cancer Center, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China.
  • Department of Urology, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China. zhjc1021@126.com.
  • Institute of Urology, Peking University, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China. zhjc1021@126.com.
  • National Urological Cancer Center, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China. zhjc1021@126.com.

Förderung

  • Natural Science Foundation of Beijing Municipality
  • National High Level Hospital Clinical Research Funding (High Quality Clinical Research Project of Peking University First Hospital)
  • National Natural Science Foundation of China
  • Capital's Funds for Health Improvement and Research

Zitieren

APA

Deng, R., Qiu, J., Shang, J., Yu, C., Tian, P., Zhao, Z., Cai, L., Zhou, J., & Gong, K. (2024). The long-term survival outcome of sporadic bilateral renal cell carcinoma and optimization of surgical treatment: a large-scale population-based cohort study. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-024-01535-5

Vancouver

Deng R, Qiu J, Shang J, Yu C, Tian P, Zhao Z, et al. The long-term survival outcome of sporadic bilateral renal cell carcinoma and optimization of surgical treatment: a large-scale population-based cohort study. Clinical and Experimental Medicine. 2024. doi:10.1007/s10238-024-01535-5

BibTeX
@article{Deng2024,
  author = {Deng, Ruiyi and Qiu, Jianhui and Shang, Jiaheng and Yu, Chaojian and Tian, Peidong and Zhao, Zihou and Cai, Lin and Zhou, Jingcheng and Gong, Kan},
  title = {The long-term survival outcome of sporadic bilateral renal cell carcinoma and optimization of surgical treatment: a large-scale population-based cohort study},
  journal = {Clinical and Experimental Medicine},
  year = {2024},
  doi = {10.1007/s10238-024-01535-5}
}
Kostenlos starten →